Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,860 | -288,989 | -224,076 | -138,472 | -67,904 |
| Depreciation Amortization | 551 | 3,251 | 2,722 | 1,821 | 911 |
| Accounts payable and accrued liabilities | -9,946 | 4,315 | -4,402 | -5,200 | -1,015 |
| Other Working Capital | -34,012 | 21,444 | -18,444 | -12,511 | -5,557 |
| Other Operating Activity | 14,283 | 38,807 | 42,257 | 19,214 | 6,754 |
| Operating Cash Flow | $-61,984 | $-221,172 | $-201,943 | $-135,148 | $-66,811 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,973 | -1,099 | -824 | -532 | -139 |
| Purchase Of Investment | -151 | -32,076 | -32,076 | -27,160 | N/A |
| Sale Of Investment | 3,000 | 29,240 | 16,440 | N/A | N/A |
| Investing Cash Flow | $-12,124 | $-3,935 | $-16,460 | $-27,692 | $-139 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 80,000 | 113,700 | 113,700 | N/A | N/A |
| Debt Repayment | N/A | -105,720 | -105,420 | N/A | N/A |
| Common Stock Issued | 2,190 | 137,946 | 137,671 | 137,388 | 137,610 |
| Other Financing Activity | 0 | 0 | -300 | 0 | 0 |
| Financing Cash Flow | $82,190 | $145,926 | $145,651 | $137,388 | $137,610 |
| Beginning Cash Position | 78,018 | 157,199 | 157,199 | 157,199 | 157,199 |
| End Cash Position | 86,100 | 78,018 | 84,447 | 131,747 | 227,859 |
| Net Cash Flow | $8,082 | $-79,181 | $-72,752 | $-25,452 | $70,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,984 | -221,172 | -201,943 | -135,148 | -66,811 |
| Capital Expenditure | -14,973 | -1,099 | -824 | -532 | -139 |
| Free Cash Flow | -76,957 | -222,271 | -202,767 | -135,680 | -66,950 |